0

Journal Articles

in Drug Therapy
 21-40 of 342 Articles
Clinical Review |  March 27, 2013
Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma:  A Systematic Review
Sandra Y. Lin, MD; Nkiruka Erekosima, MD, MPH; Julia M. Kim, MD, MPH; et al.
JAMA. 2013;309(12):1278-1288. doi:10.1001/jama.2013.2049.
INCLUDES: CME , Supplemental Content
Editorial |  March 27, 2013 FREE
Concerns About Reliability in the Trial to Assess Chelation Therapy (TACT)
Steven E. Nissen, MD
JAMA. 2013;309(12):1293-1294. doi:10.1001/jama.2013.2778.
Editorial |  March 27, 2013
Is Sublingual Immunotherapy Ready for Use in the United States?
Harold S. Nelson, MD
JAMA. 2013;309(12):1297-1298. doi:10.1001/jama.2013.2739.
Editorial |  March 27, 2013
Macrolides and Bronchiectasis:  Clinical Benefit With a Resistance Price
J. Stuart Elborn, MD; Michael M. Tunney, PhD
JAMA. 2013;309(12):1295-1296. doi:10.1001/jama.2013.2780.
Original Contribution |  March 27, 2013
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis:  The BAT Randomized Controlled Trial
Josje Altenburg, MD; Casper S. de Graaff, MD; Ymkje Stienstra, MD, PhD, MSc; et al.
JAMA. 2013;309(12):1251-1259. doi:10.1001/jama.2013.1937.
INCLUDES: , Supplemental Content
Original Contribution |  March 27, 2013
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction:  A Randomized Clinical Trial
Margaret M. Redfield, MD; Horng H. Chen, MD; Barry A. Borlaug, MD; et al.
JAMA. 2013;309(12):1268-1277. doi:10.1001/jama.2013.2024.
INCLUDES: , Supplemental Content
Viewpoint |  March 06, 2013
Responding to the Outbreak of Invasive Fungal Infections:  The Value of Public Health to Americans
Beth P. Bell, MD, MPH; Rima F. Khabbaz, MD
JAMA. 2013;309(9):883-884. doi:10.1001/jama.2013.526.
JAMA Clinical Evidence Synopsis |  March 06, 2013
Antiplatelet Therapy to Prevent Cardiovascular Events and Mortality in Patients With Intermittent Claudication
Peng Foo Wong, MD, FRCS (Gen); Lee-Yee Chong, BSc, PhD; Gerard Stansby, MChir, FRCS
JAMA. 2013;309(9):926-927. doi:10.1001/jama.2013.1490.
Original Contribution |  March 06, 2013
Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
Kevin L. Winthrop, MD, MPH; John W. Baddley, MD, MSPH; Lang Chen, PhD; et al.
JAMA. 2013;309(9):887-895. doi:10.1001/jama.2013.1099.
INCLUDES: , Supplemental Content
Viewpoint |  March 06, 2013
Improving Opioid Prescribing:  The New York City Recommendations
David N. Juurlink, MD, PhD; Irfan A. Dhalla, MD, MSc; Lewis S. Nelson, MD
JAMA. 2013;309(9):879-880. doi:10.1001/jama.2013.1139.
From the Centers for Disease Control and Prevention |  March 06, 2013
Interruptions in Supplies of Second-Line Antituberculosis Drugs—United States, 2005-2012
JAMA. 2013;309(9):866-868. doi:10.1001/jama.2013.691.
Clinical Crossroads |  March 06, 2013
Chronic Back Pain With Possible Prescription Opioid Misuse
Daniel P. Alford, MD, MPH
JAMA. 2013;309(9):919-925. doi:10.1001/jama.2013.522.
INCLUDES: CME
Caring for the Critically Ill Patient |  February 20, 2013
Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation:  A Systematic Review and Meta-analysis
Ryan Zarychanski, MD, MSc; Ahmed M. Abou-Setta, MD, PhD; Alexis F. Turgeon, MD, MSc; et al.
JAMA. 2013;309(7):678-688. doi:10.1001/jama.2013.430.
INCLUDES: , Supplemental Content
JAMA Clinical Evidence Synopsis |  February 20, 2013
Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections
Philipp Schuetz, MD, MPH; Matthias Briel, MD, MSc; Beat Mueller, MD
JAMA. 2013;309(7):717-718. doi:10.1001/jama.2013.697.
Research Letters |  February 20, 2013
Pharmaceutical Overdose Deaths, United States, 2010
Christopher M. Jones, PharmD; Karin A. Mack, PhD; Leonard J. Paulozzi, MD
JAMA. 2013;309(7):657-659. doi:10.1001/jama.2013.272.
From the Centers for Disease Control and Prevention |  February 20, 2013
Notes from the Field: National Shortage of Isoniazid 300 mg Tablets
JAMA. 2013;309(7):653. doi:10.1001/jama.2013.223.
Editorial |  February 13, 2013
Antibiotics for Skin Infections:  New Study Design and a Step Toward Shorter Course Therapy
Shira Doron, MD; Helen W. Boucher, MD
JAMA. 2013;309(6):609-611. doi:10.1001/jama.2013.604.
Editorial |  February 13, 2013 FREE
Restoring Confidence in the Pharmaceutical Industry
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2013;309(6):607-609. doi:10.1001/jama.2013.58.
Medical News and Perspectives |  February 13, 2013
Indian Public Health Leaders Move to Reduce Antimicrobial Resistance
Mike Mitka, MSJ
JAMA. 2013;309(6):531-532. doi:10.1001/jama.2013.297.
Medical News and Perspectives |  February 13, 2013
Despite Curbing New Drug Shortages, Shortfall of Drugs a Persistent Problem
Bridget M. Kuehn, MSJ
JAMA. 2013;309(6):532-533. doi:10.1001/jama.2012.216795.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems